These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9883551)

  • 21. Power and sample size simulations for Randomized Play-the-Winner rules.
    Guimaraes P; Palesch Y
    Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size determination for constrained longitudinal data analysis.
    Lu K; Mehrotra DV; Liu G
    Stat Med; 2009 Feb; 28(4):679-99. PubMed ID: 19051207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shift in re-randomization distribution with conditional randomization test.
    Kuznetsova OM; Tymofyeyev Y
    Pharm Stat; 2013; 12(2):82-91. PubMed ID: 23408550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias.
    Borm GF; Melis RJ; Teerenstra S; Peer PG
    Stat Med; 2005 Dec; 24(23):3535-47. PubMed ID: 16007575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How important is exact balance in treatment and control sample sizes to evaluations?
    Elliott MN; McCaffrey DF; Lockwood JR
    J Subst Abuse Treat; 2007 Jul; 33(1):107-10. PubMed ID: 17376636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size re-estimation in cluster randomization trials.
    Lake S; Kammann E; Klar N; Betensky R
    Stat Med; 2002 May; 21(10):1337-50. PubMed ID: 12185888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment allocation for nonlinear models in clinical trials: the logistic model.
    Begg CB; Kalish LA
    Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
    Correa JA; Bellavance F
    Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constrained randomization in a therapeutic efficacy trial.
    Tamura RN; Mills BJ; Lovelace JK
    Biometrics; 1993 Mar; 49(1):249-58. PubMed ID: 8513107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.
    Proschan M; Follmann D
    Stat Med; 2008 Mar; 27(6):795-809. PubMed ID: 17594680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reverse propensity score to detect selection bias and correct for baseline imbalances.
    Berger VW
    Stat Med; 2005 Sep; 24(18):2777-87. PubMed ID: 15981305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.
    Shepherd BE; Gilbert PB; Jemiai Y; Rotnitzky A
    Biometrics; 2006 Jun; 62(2):332-42. PubMed ID: 16918897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of methods to analyse continuous data from pseudo cluster randomized trials.
    Teerenstra S; Moerbeek M; Melis RJ; Borm GF
    Stat Med; 2007 Sep; 26(22):4100-15. PubMed ID: 17328006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of randomization on the analysis of clinical trials.
    Rosenkranz GK
    Stat Med; 2011 Dec; 30(30):3475-87. PubMed ID: 21953285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials.
    Anisimov VV
    Pharm Stat; 2011; 10(1):50-9. PubMed ID: 20112277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.